Novartis Bioventures Ltd 13D/13G Filings for Annexon, Inc. (ANNX)

Novartis Bioventures Ltd 13D and 13G filings for Annexon, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-02-11
4:30 pm
Sale		2021-12-3113GAnnexon, Inc.
ANNX		Novartis Bioventures Ltd910,747
2.370%		-1,196,497decrease
(-56.78%)		Filing
2021-01-29
09:07 am
Purchase		2020-12-3113GAnnexon, Inc.
ANNX		Novartis Bioventures Ltd2,107,244
5.520%		2,107,244increase
(New Position)		Filing